← Browse by Condition
Medical Condition

antibiotic prophylaxis

Total Trials
3
Recruiting Now
3
Trial Phases
Phase 4

ClinicalMetric tracks all active clinical trials for antibiotic prophylaxis sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — antibiotic prophylaxis Clinical Trials

How many clinical trials are currently recruiting for antibiotic prophylaxis?
ClinicalMetric currently tracks 3 actively recruiting clinical trials for antibiotic prophylaxis, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 3. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for antibiotic prophylaxis?
antibiotic prophylaxis research spans Phase 4 (3 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a antibiotic prophylaxis clinical trial?
Eligibility criteria for antibiotic prophylaxis trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 4
3
Top Sponsors
Dow University of Health Sciences 1 trial
University of Sao Paulo General Hospital 1 trial
Sheba Medical Center 1 trial

Recruiting Clinical Trials

NCT07894016 Phase 4
Recruiting
Comparison of Amoxicillin, Clindamycin and Azithromycin Single Doses Antibiotic Prophylaxis in Patient Undergoing Lower Third Molar Extraction
Enrollment
105 pts
Location
Pakistan
Sponsor
Dow University of Health Scien...
View Trial →
NCT07275580 Phase 4
Recruiting
Antibiotic Prophylaxis After Simple Tooth Extraction in Immunosuppressed Patients With Autoimmune Rheumatic Diseases
Enrollment
352 pts
Location
Brazil
Sponsor
University of Sao Paulo Genera...
View Trial →
NCT07183462 Phase 4
Recruiting
Azithromycin and Ampicillin for Late PPROM
Enrollment
311 pts
Location
Israel
Sponsor
Sheba Medical Center
View Trial →

Related Conditions

wisdom tooth removal (1) single dose (1) autoimmune rheumatic diseases (1) tooth extraction (1) infection prevention (1) pregnancy complications infectious (1) premature birth (1) neonatal diseases and abnormalities (1) latency period (1) prematurity (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology